{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:35:49Z","timestamp":1789756549896,"version":"4.0.1"},"reference-count":44,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T00:00:00Z","timestamp":1482364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>High\u2010quality data on the management of autoimmune hepatitis (<jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content>) are scarce. Despite published guidelines, management of <jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content> is still expert based rather than evidence based.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To survey expert hepatologists, asking each to describe their practices in the management of patients with <jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A survey questionnaire was distributed to members of the International AIH Group. The questionnaire consisted of four clinical scenarios on different presentations of <jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sixty surveys were sent, out of which 37 were returned. None reported budesonide as a first line induction agent for the acute presentation of <jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content>. Five (14%) participants reported using thiopurine S\u2010methyltransferase measurements before commencement of thiopurine maintenance therapy. Thirteen (35%) routinely perform liver biopsy at 2 years of biochemical remission. If histological inflammatory activity is absent, four (11%) participants reduced azathioprine, whereas 10 (27%) attempted withdrawal altogether. Regarding the management of difficult\u2010to\u2010treat patients, mycophenolate mofetil is the most widely used second\u2010line agent (<jats:italic>n<\/jats:italic> = ~450 in 28 centres), whereas tacrolimus (<jats:italic>n<\/jats:italic> = ~115 in 21 centres) and ciclosporin (<jats:italic>n<\/jats:italic> = ~112 in 18 centres) are less often reported. One centre reported considerable experience with infliximab, while rescue therapy with rituximab has been tried in seven centres.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There is a wide variation in the management of patients with autoimmune hepatitis even among the most expert in the field. Although good quality evidence is lacking, there is considerable experience with second\u2010line therapies. Future prospective studies should address these issues, so that we move from an expert\u2010 to an evidence\u2010 and personalised\u2010based care in autoimmune hepatitis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/apt.13907","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T07:12:58Z","timestamp":1482390778000},"page":"723-732","source":"Crossref","is-referenced-by-count":73,"title":["Expert clinical management of autoimmune hepatitis in the real world"],"prefix":"10.1111","volume":"45","author":[{"given":"R.","family":"Liberal","sequence":"first","affiliation":[{"name":"London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4066-7593","authenticated-orcid":false,"given":"Y. S.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Andrade","sequence":"additional","affiliation":[{"name":"M\u00e1laga Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bouma","sequence":"additional","affiliation":[{"name":"Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. N.","family":"Dalekos","sequence":"additional","affiliation":[{"name":"Larissa Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Floreani","sequence":"additional","affiliation":[{"name":"Padova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gleeson","sequence":"additional","affiliation":[{"name":"Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Hirschfield","sequence":"additional","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Invernizzi","sequence":"additional","affiliation":[{"name":"Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lenzi","sequence":"additional","affiliation":[{"name":"Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. W.","family":"Lohse","sequence":"additional","affiliation":[{"name":"Hamburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Macedo","sequence":"additional","affiliation":[{"name":"Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Milkiewicz","sequence":"additional","affiliation":[{"name":"Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Terziroli","sequence":"additional","affiliation":[{"name":"Lugano Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"van Hoek","sequence":"additional","affiliation":[{"name":"Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Vierling","sequence":"additional","affiliation":[{"name":"Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Heneghan","sequence":"additional","affiliation":[{"name":"London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the International Autoimmune Hepatitis Group (IAIHG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,12,22]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050408"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.10.020"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62163-1"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802130183"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000440709"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.qjmed.a067264"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)33223-8"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)92125-9"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.08.012"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23584"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.235259"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.04.026"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.046"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.01.037"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20345"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12039"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25760"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12223"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.10.018"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318154af74"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.09.009"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26198"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.09.037"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80271-8"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01107.x"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.04.006"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02180.x"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/891252"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04727.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13584"},{"key":"e_1_2_7_35_1","first-page":"771","article-title":"Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open\u2010label preliminary trial","volume":"90","author":"Thiel DH","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000139050.67178.be"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04749.x"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1095351"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00807.x"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010683817344"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.010"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/512624"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i23.3232"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12381"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12470"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.13907","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.13907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T11:37:00Z","timestamp":1694432220000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.13907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,22]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.1111\/apt.13907"],"URL":"https:\/\/doi.org\/10.1111\/apt.13907","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,22]]}}}